Every major medical meeting has stories that set the place buzzing. At the 2009 European Society of Cardiology meeting the results of three trials – Re-LY, PLATO, and MADIT-CRT – provided that buzz. We reported not only the results, but provided and assessment of how two investigational drugs and a cardiac resynchronization device may change practice and what regulatory, economic, or "turf" issues could quash that potential.
Read "Will HotLine Trials Change Practice?"
See the archived story and questionnaire in which the reporter writes about how this story was written.